Journal of Neuro-Oncology Q1 Unclaimed
The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.Why publish with us
A unified resource for multi-disciplinary clinicians and researchers in neuro-oncology.
In our special topical issues, global experts address current challenges and contemporary topics.
Our internationally renowned advisers collaborate to deliver quick first decisions to authors and rapid publication.
We provide high levels of author satisfaction, with 92% of our published authors reporting that they would definitely or probably publish with us again. It has an SJR impact factor of 1,178.
Journal of Neuro-Oncology focuses its scope in these topics and keywords: glioblastoma, tumor, brain, cell, patients, human, glioma, study, cancer, factor, ...
Type of Copyright:
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
1,178SJR Impact factor
301Total Docs (Last Year)
837Total Docs (3 years)
3384Total Cites (3 years)
810Citable Docs (3 years)
3.68Cites/Doc (2 years)
Best articles by citations
Two Different Mechanisms of Apoptosis Resistance Observed in Interferon- Induced Apoptosis of Human Glioma CellsView more
CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal componentView more
Unusual Metastatic Features in a Patient with Concomitant Malignant Orbital Melanoma and Prostate CarcinomaView more
The Effects of Antisense AKT2 RNA on the Inhibition of Malignant Glioma Cell Growth in vitro and in vivoView more
Toxicity and Cerebrospinal Fluid Levels of Carboplatin Chronically Infused into the Brainstem of a PrimateView more
Malignant Intracranial Epithelioid Hemangioendothelioma Presumably Originating from the Lung: Case ReportView more
Epithelioid Hemangioendothelioma of the Infundibular-Hypothalamic Region: Case Report and Literature ReviewView more
Maintenance of fertility following treatment with temozolomide for a high grade astrocytomaView more
CXCL12 in Malignant Glial Tumors: A Possible Role in Angiogenesis and Cross-Talk between Endothelial and Tumoral CellsView more
Advances in surgical management of malignancies of the cranial base: the extended transbasal approachView more
A Prospective Blinded Study of the Predictive Value of an Extreme Drug Resistance Assay in Patients Receiving CPT-11 for Recurrent GliomaView more
Primary Leptomeningeal Sarcomatosis; A Pathology Proven Case with Challenging MRI and Clinical FindingsView more
Radiation-induced Tumor after Stereotactic Radiosurgery and Whole Brain Radiotherapy: Case Report and Literature ReviewView more
Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis studyView more